Katherine L Kahn

Rand Corporation

$9,399,762

Attributed

$9,399,762

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.3M · FY2005–11

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

Funding mix

By agency

NIH$20,003,261 · 3

AHRQ$255,041 · 2

By mechanism

U01$18,120,649 · 3

R01$1,882,612 · 1

R21$255,041 · 1

Top collaborators

Most similar at Rand Corporation

Same institution · by research overlap

Michael D Hurd$38,668,869
Arie Kapteyn$101,412,267
Dana P Goldman$26,931,376
John A Strauss$16,922,451
Nicole A Maestas$13,244,181

Others in their field

Top investigators on “Outcomes Research”

Sonia M Thomas · Research Triangle Institute$700,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
Chanza Baytop · Westat, Inc.$271,217,917
James Dennis Neaton · Northwestern University$211,104,631
Gregory H Reaman · National Childhood Cancer Foundation$200,641,185
Mary M Horowitz · Medical College Of Wisconsin$194,506,555

Research focus

Outcomes ResearchClinical ResearchHuman SubjectData CollectionCooperative StudyHealth Care QualityQuality Of CareMedical RecordsRacial /Ethnic DifferenceVariantCancer Rehabilitation /CareManaged CareHealth Services Research TagCaringReportingCancer CareDiagnostic Neoplasm StagingComorbidityDiagnosisHealth Care Service EvaluationColorectal CancerColorectal NeoplasmsCancer Care Outcomes Research And Surveillance ConsortiumLung